Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer.

The overexpression of eukaryotic translation initiation factor 4E (eIF4E), a key regulator of protein synthesis, is involved in the malignant progression of human breast cancer. This study investigates the relationship between eIF4E and angiogenesis, as well as their prognostic impact in patients with human breast cancer.
Immunohistochemical staining was used to determine protein expression of eIF4E, vascular endothelial growth factor (VEGF), interleukin-8 (IL-8), and CD105 in a set of 122 formalin-fixed, paraffin-embedded primary breast cancer tissues. Expression of eIF4E in positive cells was characterized by cytoplasmic staining. Evaluation of VEGF and IL-8 in the same tissue established the angiogenic profiles, while CD105 was used as an indicator of microvessel density (MVD).
A significant relationship was found between the level of eIF4E expression and histological grade (P = 0.016). VEGF, IL-8, and MVD were closely related to tumor grade (P = 0.003, P = 0.022, and P < 0.001, respectively) and clinical stage (P = 0.007, P = 0.048, and P < 0.001, respectively). Expression of eIF4E was also significantly correlated with VEGF (P = 0.007), IL-8 (P = 0.007), and MVD (P = 0.006). Patients overexpressing eIF4E had significantly worse overall (P = 0.01) and disease-free survival (P = 0.006). When eIF4E, histological grade, tumor stage, ER, PR, Her-2 status and the levels of VEGF, IL-8, MVD were included in a multivariate Cox regression analysis, eIF4E emerged as an independent prognostic factor for breast cancer (P = 0.001), along with stage (P = 0.005), node status (P = 0.046), and MVD (P = 0.004).
These results suggest that higher eIF4E expression correlates with both angiogenesis and vascular invasion of cancer cells, and could therefore serve as a useful histological predictor for less favorable outcome in breast cancer patients, as well as represent a potential therapeutic target.
AuthorsSheng Zhou, Guo-Ping Wang, Cong Liu, Muxiang Zhou
JournalBMC cancer (BMC Cancer) Vol. 6 Pg. 231 ( 2006) ISSN: 1471-2407 [Electronic] England
PMID17010208 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • Biomarkers, Tumor
  • ENG protein, human
  • Eukaryotic Initiation Factor-4E
  • Interleukin-8
  • Neoplasm Proteins
  • Receptors, Cell Surface
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Adult
  • Aged
  • Antigens, CD (biosynthesis, genetics)
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms (blood supply, chemistry, mortality)
  • Disease Progression
  • Disease-Free Survival
  • Eukaryotic Initiation Factor-4E (physiology)
  • Female
  • Follow-Up Studies
  • Gene Expression Regulation, Neoplastic (genetics)
  • Humans
  • Interleukin-8 (biosynthesis, genetics)
  • Life Tables
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Proteins (biosynthesis, genetics, physiology)
  • Neovascularization, Pathologic (metabolism)
  • Prognosis
  • Proportional Hazards Models
  • Protein Biosynthesis
  • Receptors, Cell Surface (biosynthesis, genetics)
  • Survival Analysis
  • Survival Rate
  • Vascular Endothelial Growth Factor A (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: